<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasma <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) levels were measured in 14 subjects with Prader-Willi syndrome, 9 subjects with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, and matched control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Mean levels in both patient groups were 2 to 3 times higher than in nonretarded moderately <z:mp ids='MP_0001261'>obese</z:mp> or retarded nonobese control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Levels in each patient group differed significantly from both control groups </plain></SENT>
<SENT sid="3" pm="."><plain>Neither the two patient groups nor the two control groups differed </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="3" ids="16865">GABA</z:chebi> levels seemed unrelated to genetic status (chromosome 15 deletion or disomy) </plain></SENT>
<SENT sid="5" pm="."><plain>These preliminary findings of elevated plasma <z:chebi fb="3" ids="16865">GABA</z:chebi> levels possibly represent a compensatory increase in presynaptic <z:chebi fb="3" ids="16865">GABA</z:chebi> release in response to hyposensitivity of a subset of <z:chebi fb="3" ids="16865">GABA</z:chebi> receptors and could produce increased postsynaptic activation of other <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="3" ids="16865">GABA</z:chebi> receptor subtypes, resulting in complex alterations of GABAergic function throughout the brain </plain></SENT>
</text></document>